When is Yescarta (axicabtagene ciloleucel) indicated for adults with diffuse large B-cell lymphoma or high-grade B-cell lymphoma after first-line chemoimmunotherapy?

Yescarta (axicabtagene ciloleucel) is indicated for adults with diffuse large B-cell lymphoma or high-grade B-cell lymphoma that relapses within 12 months of completing first-line chemoimmunotherapy or is refractory to that treatment.